Ifeoluwapo Oyebola Asekun-Olarinmoye

Ifeoluwapo Oyebola Asekun-Olarinmoye

Auto-generated profile, based on publicly available information

Ifeoluwapo Oyebola Asekun-Olarinmoye

Faculty of Basic Medical Sciences, University of Ilesa, Ilesa, Osun State, Nigeria

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in INQUIRY: The Journal of Health Care Organization, Provision, and Financing
Verified
Journal Article
Open access
OOOlusesan Oyewole Oyerinde
Olusesan Oyewole Oyerinde
ENEssien Annieye Nkanga
Essien Annieye Nkanga
IOIfeoluwa Emmanuel Oyerinde
Ifeoluwa Emmanuel Oyerinde
OAOnamade Akintoye
Onamade Akintoye
IAIfeoluwa Asekun-Olarinmoye
Ifeoluwa Asekun-Olarinmoye
QAQuadri Alabi
Quadri Alabi
Anemia progresses due to low red blood cells counts or hemoglobin. The World Health Organization (WHO) has suggested the condition to be a serious global public health problem that affects pregnant women worldwide. Anemic pregnant women may suffer post-partum hemorrhage, pre-term delivery, seizures, and severe cases of anemia that potentially lead to cardiac failure or death. However, it is pertinent for pregnant women and health service providers to have the adequate knowledge about the factors associated with anemia in pregnancy. Thus, this study assessed the factors associated with anemia in pregnancy women attending primary healthcare (PHC) centers in Ibeju-Lekki Local government area, Lagos state. This study employed descriptive cross-sectional design using multi-stage sampling method to recruit 295 pregnant women into the study. Data were collected using a semi-structured, self-administered questionnaire. The recruited participants (56.6%) were majorly in their third trimester, of which their mean age was 28.7 ± 5.9 years. About 80.7% of the participants were married, having a mean knowledge score of 6.6 ± 3.2. More than half of respondents (56.3%) were anemic and had a poor knowledge (50.5%) of anemia in pregnancy. The mean hemoglobin concentration within the population was 11.06 ± 0.73 g/dl with a range of 8.3 to 12.0. There was no significant association between the respondents’ knowledge of anemia in pregnancy and anemic status (X2 = 0.549; P = .45). However, this study observed a significant association between dietary diversity score and anemic status (X2 = 8.66; P = .01) and the trimester status of respondents’ first antenatal visit (X2 = 9.603; P = .008). The study concluded that anemia in pregnancy was associated with maternal factors such as their first antenatal visit and the dietary diversity score. Due to this, proper education of pregnant women on anemia by health workers during antenatal clinics or visits should be prioritize to improve their anemia status.

20 November 2024 in Afro-Egyptian Journal of Infectious and Endemic Diseases
Verified
Journal Article
Open access
PDF file
SESeyi Samson Enitan
Seyi Samson Enitan
MIMichael Unata Iduh
Michael Unata Iduh
GIGrace Eleojo Itodo
Grace Eleojo Itodo
AAAmeh Raphael Adole
Ameh Raphael Adole
IAIfeoluwapo Oyebola Asekun-Olarinmoye
Ifeoluwapo Oyebola Asekun-Olarinmoye
RARhoda Temilola Akinpelu
Rhoda Temilola Akinpelu
Measles remains a significant public health challenge in Nigeria, contributing to substantial morbidity and mortality among children despite the availability of effective vaccines. This narrative review aims to synthesize current literature on the epidemiological trends, drivers, barriers, and public health interventions related to measles control in Nigeria. A comprehensive search was conducted across Google Scholar, Scopus, and PubMed for articles published between 2008 and 2024. The search strategy utilized keywords such as “measles,” “Nigeria,” “epidemiology,” “vaccination,” and “public health interventions.” Articles were selected based on predetermined inclusion and exclusion criteria, focusing on studies that specifically addressed measles and its control measures in Nigeria. The review highlights fluctuating measles incidence with periodic outbreaks exacerbated by low immunization coverage, population displacement, and rapid urbanization. Suboptimal vaccination rates for both the first (MCV1) and second (MCV2) doses leave many children vulnerable. Barriers to effective control include misinformation, vaccine hesitancy, insecurity in conflict-affected regions, and logistical challenges in vaccine distribution. Public health interventions, including enhanced immunization campaigns, community engagement, and integrated health services, are essential for improving vaccination coverage and combating measles. Achieving effective measles control in Nigeria requires sustained commitment, adequate funding, and international collaboration to ensure the health and well-being of Nigerian children.

28 December 2024 in Avicenna Journal of Clinical Microbiology and Infection
Verified
Journal Article
Open access
PDF file
SESeyi Samson Enitan
Seyi Samson Enitan
PSPrincess Hephzibah Soboyejo
Princess Hephzibah Soboyejo
KDKester Awharentomah Digban
Kester Awharentomah Digban
MIMichael Unata Iduh
Michael Unata Iduh
IAIfeoluwapo Oyebola Asekun-Olarinmoye
Ifeoluwapo Oyebola Asekun-Olarinmoye
AOAyomide Oluwatobiloba Okuneye
Ayomide Oluwatobiloba Okuneye
Recent advancements in the treatment of hepatitis C virus (HCV) infection have significantly advanced the goal of achieving a hepatitis C-free world. The introduction of direct-acting antivirals (DAAs) has revolutionized treatment, offering over 95% cure rates, shorter treatment durations, and fewer side effects. Pan-genotypic regimens, such as sofosbuvir/velpatasvir, have further simplified treatment by being effective across all HCV genotypes. Despite these advancements, substantial challenges persist globally. An estimated 50 million people are living with chronic HCV worldwide, yet many remain undiagnosed, particularly in low- and middle-income countries, where there is limited healthcare infrastructure. High treatment costs further restrict access to these life-saving therapies. Reinfection rates remain high among certain populations, such as people who inject drugs (PWIDs), and stigma continues to deter individuals from seeking testing and treatment. To advance HCV elimination, future efforts must prioritize universal screening, affordable treatment, improved diagnostic technologies, and intensified research into vaccine development. Strengthened global and local collaboration is essential to overcome these challenges and reduce the global HCV burden.